BioSpace News Archive

INSYS Therapeutics Provides Update on NASDAQ Trading Hold

INSYS received a series of questions on Friday from NASDAQ.

October 31, 2017
·
2 min read
Pluristem Announces Pricing of Public Offering of Common Stock on the Tel Aviv Stock Exchange

The Company received overall orders for the purchase of approximately 13,500,000 shares at different prices for a total aggregate amount of approximately $21.8 million.

October 31, 2017
·
5 min read
Biotech Bay

Verseon to Present Preclinical Data on Novel Anticancer Candidates for Use against Multidrug Resistant Cancers

The results will be shown at the BIO-Europe conference held in Berlin from November 6–8, 2017.

October 31, 2017
·
1 min read
Policy

Tigenix Provides Regulatory Update on Cx601 EU Marketing Authorization Application Procedure - Oct. 31, 2017

An Oral Explanation is part of the MA Application procedure for many novel orphan drugs.

October 31, 2017
·
6 min read
Business

FibroGen to Report Third Quarter Financial Results on Wednesday, November 8, 2017

The company will host a conference call to discuss financial results and provide a business update at 5:00 p.m. ET (2:00 p.m. PT).

October 31, 2017
·
2 min read
Business

Innophos Declares Quarterly Dividend

Innophos today announced that its Board of Directors had declared a quarterly dividend of $0.48 per share of common stock.

October 31, 2017
·
1 min read
Business

Osiris Therapeutics, Inc. Provides Update on Audit of 2015 and 2016 Financial Statements

The Company continues to work diligently to complete the audits and to regain compliance with its SEC reporting requirements as soon as practicable.

October 31, 2017
·
4 min read
BioMidwest

METTLER TOLEDO to Exhibit At 2017 AAPS Annual Meeting and Exposition in San Diego, CA

The forum allows for the exchange of ideas, presentation of scientific data, examination of regulatory and ethical concerns as well as learning and networking.

October 31, 2017
·
1 min read
Cancellation of Publicly Held Actelion Shares and Delisting From SIX Swiss Exchange as of November 7, 2017

The holders of the cancelled Actelion Shares will be paid a cash compensation in the amount of $280 for each cancelled Actelion Share.

October 31, 2017
·
4 min read
TCT 2017: BIOTRONIK Symposium Highlights Differing Roles of Drug-Eluting Stents and Magnesium Scaffolds in Clinical Practice

Data presented at the BIOTRONIK-sponsored symposium on the Orsiro1 drug-eluting stent (DES) demonstrate why Orsiro is gaining prominence in the crowded DES market.

October 31, 2017
·
3 min read